期刊文献+

逍遥散抗抑郁有效部位配伍对应激抑郁模型小鼠行为学及睡眠时间的影响 被引量:3

Effect of the Compatibility of Active Fractions from Xiaoyaosan on Stress Model in Mice
下载PDF
导出
摘要 目的研究逍遥散抗抑郁有效部位(A,B4,B3)配伍对应激抑郁模型小鼠行为学及睡眠时间的影响。方法逍遥散抗抑郁有效部位采用L9(34)正交设计进行配伍研究,以配伍后的组份及文拉法辛为干预药物,灌胃给予15 d的实验药物。实验过程中,定期测定小鼠体重与自主活动。于第14天给药后1 h,采用急性应激抑郁模型(小鼠悬尾)观测配伍组份对小鼠悬尾不动时间的影响,初步筛选最佳配伍比;第15天给药后1 h,各组小鼠按45 mg/kg腹腔注射阈剂量的戊巴比妥钠生理盐水注射液,准确记录注射结束时间、翻正反射消失时间、翻正反射恢复时间。观测配伍组份对戊巴比妥钠所致小鼠睡眠时间的影响。结果与空白对照组比较,当配伍部位按生药量计,A为138.9 g/kg,B4为46.3 g/kg,B3为23.1 g/kg时,可显著减少小鼠悬尾不动时间(P<0.001),且不影响小鼠自主活动量,并能够明显延长小鼠睡眠潜伏期(P<0.01)和显著地缩短小鼠睡眠持续时间(P<0.001)。结论逍遥散抗抑郁有效部位按生药量计,A为138.9 g/kg,B4为46.3 g/kg,B3为23.1 g/kg时,抗抑郁作用最佳,且在最佳配伍比时,能明显缩短阈剂量戊巴比妥钠所致小鼠睡眠时间。 Objective To study the effect of the compatibility of three active fractions from Xiaoyaosan on changes of behavior and sleep time on stress model in mice. Methods The active fractions(A,B4,B3) were combined into different compatibility groups using L9(34) orthogonal design.The mice were treated with the compatibility groups or positive drug(venlafaxine) for 15 days.During the experiment,body weight,data of open-field test(OFT) were detected.On the 14th day,the tail suspension test(TST) in mice was conducted 1 h after the drug treatment to screen the best anti-depression compatibility group.1 h after the last drug treatment,ip 45 mg/kg barbital sodium.To write down ip time,disappeance time of righting reflex,refreshment time of righting reflex. Results The locomotor activity in mice OFT was not affected by the treatment of drugs.The immobility time of the mice in the mouse TST treated with active fractions(A:138.9 g/kg,B4:46.3 g/kg,B3:23.1 g/kg) increased significantly(P〈0.001) compared with control group,the compatibility group extended mice sleep latency and decreased sleep time significantly(compare with control group,P〈0.01 and P〈0.001,respectively). Conclusion The compatibility group(A:138.9 g/kg,B4:46.3 g/kg,B3:23.1 g/kg) has the best anti-depression effect and can decrease sleep time.
出处 《时珍国医国药》 CAS CSCD 北大核心 2012年第7期1684-1686,共3页 Lishizhen Medicine and Materia Medica Research
基金 国家自然科学基金(No.30901960) 国家国际科技合作计划项目(No.2011DFA32630)
关键词 逍遥散 抗抑郁 有效部位 配伍 睡眠时间 Xiaoyaosan; Anti-depression; Active fractions; Compatibility; Sleep time
  • 相关文献

参考文献9

  • 1Dai Y T,Li Z Y,Xue L M ,et al. Metabolomics study on the antidepres- sion effect of xiaoyaosan on rat model of chronic unpredictable mild stress [ J ]. J Ethnopharmacology ,2010,128 ( 2 ) :482.
  • 2Zhou Y Z, Lu L L, Li Z F, et al. Antidepressant - like effects of the frac- tions of Xiaoyaosan on rat mode/ of chronic unpredictable mild stress [ J ]. J Ethnophannacology ,2011,137 ( 1 ) :236.
  • 3邓先华,孙学礼,张波,舒放,唐娴,刘协和.文拉法辛对抑郁症患者睡眠的影响[J].华西药学杂志,2007,22(3):351-353. 被引量:6
  • 4李艳,徐碧云,肖芳,欧碧阳,杨志敏.加味逍遥散对心理应激性失眠患者睡眠的影响[J].中国中西医结合杂志,2009,29(3):208-211. 被引量:11
  • 5Stem L, Chermat R, Thierry B, et al. The tail suspension test: a new method for screening antidepressants in Mice [ J ]. Psychopharmacolo- gy, 1985,85 (3) :367.
  • 6Thase M D. Antidepressant treatment of the depressed patient with in- somnia[ J]. J Clin Psychiatry, 1999,60( 17 ) :28.
  • 7Trivedi MH, Rush A J, Armitage R, et al. Effects of fluoxetine on the polysomnogram in outpatients with major depression [J]. Neuropsycho- pharmacology, 1999,20 ( 5 ) :447.
  • 8罗和春,钱瑞琴,赵学英,毕娟,信红岭,蒋学柱,许珂,阎少校.丹栀逍遥散治疗抑郁症的临床疗效观察[J].中国中西医结合杂志,2006,26(3):212-214. 被引量:70
  • 9Giedke H, Klingberg S, Sehwarzler F, et al. Direct comparison of total sleep deprivation and late partial sleep deprivation in the treatment of major depression [J]. J Affecti Disorders,2003,76( 3 ) :85.

二级参考文献20

  • 1李强,亢万虎,谭庆荣,张樟进,高成阁,行养玲,杨向东,张风刚,王葳,王怀海,陈策,马现仓,张瑞国,郭丽.卡马西平单用及其与逍遥散合用治疗双相情感障碍随机双盲安慰剂对照临床研究[J].中国临床药理学杂志,2005,21(5):336-340. 被引量:7
  • 2罗和春,钱瑞琴,赵学英,毕娟,信红岭,蒋学柱,许珂,阎少校.丹栀逍遥散治疗抑郁症的临床疗效观察[J].中国中西医结合杂志,2006,26(3):212-214. 被引量:70
  • 3刘贤臣,唐茂芹,胡蕾,王爱祯,吴宏新,赵贵芳,高春霓,李万顺.匹兹堡睡眠质量指数的信度和效度研究[J].中华精神科杂志,1996,29(2):103-107. 被引量:3584
  • 4张明圆.精神科评定量表手册[M].长沙:湖南科技出版社,1998..
  • 5汪向东 王希林 等.心理卫生评定量表手册[M].北京:中国心理卫生杂志社,1999.235.
  • 6中华医学会精神科分会编.中国精神障碍分类与诊断标准[M].济南:山东科学技术出版社,2001.118.
  • 7卫生部药典委员会编.中国药典(一部)[M].北京:化学工业出版社,2000.214.
  • 8Luthringer R,Toussaint M,Schahenbrand N,et al.A double-blind,placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression[J].Psychopharmacology Bulletin,1996,32(4):637-646.
  • 9Rechtschaffen A,Kales A.A manual of standardized terminology,techniques,and scoring system for sleep stages in human subjects[M].3rd.Los Angels:Brain Information Service/Brain research Institute of University of Califonia,1973.1-2.
  • 10Berger M,Van Calker D,Riemann D.Sleep and manipulations of the sleep-wake rhythm in depression[J].Acta Psychiatrica Scandinavica.Supplementum,2003,(418):83-91.

共引文献84

同被引文献19

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部